A clinical trial is a controlled study to evaluate the safety and efficacy (how well it works) of an experimental drug treatment. These studies are required before a drug can be approved by a regulatory agency such as the Food and Drug Administration (FDA) or European Medicines Agency (EMA). The purpose of a clinical trial is to evaluate whether a potential new therapy is safe and effective. Patients interested in participating in a clinical trial must meet certain eligibility criteria and be willing to follow directions of the physician in charge of the study.
Clinical Trials with pepinemab
SIGNAL-AD Alzheimer’s Disease
Evaluating the Safety and Efficacy of our drug Pepinemab in Patients with Alzheimer’s Disease.
Condition(s) Alzheimer Disease (AD)
Alzheimer’s Association, Alzheimer’s Drug Discovery Foundation
Keynote B84 Head and Neck Cancer
Evaluating the Safety and Efficacy of our Drug Pepinemab in Combination with Pembrolizumab in Patients with Advanced, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck.
Condition(s) Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)